CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Alladapt Immunotherapeutics, Inc.

For profitWebsite ↗

Also known as: Alladapt Immunotherapeutics, Inc. | VP of Clinical Development, Alladapt Immunotherapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 14, 2022

Timeline

2010s

Jun 1, 2018
Alladapt Immunotherapeutics, Inc.— Founded

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

adp101

Recent trials (3)

NCT05243719Lead sponsorPhase 1/Phase 2Mar 14, 2022
NCT05243719Study directorPhase 1/Phase 2Mar 14, 2022
NCT04856865Lead sponsorPhase 1/Phase 2Apr 20, 2021

Details

Founded: Palo Alto, CA, US Jun 1, 2018
Last known activity: Mar 14, 2022